Secukinumab으로 치료 중인 건선 환자에서 발생한 역설적 아토피 습 진양 반응 1예
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김동성 | - |
dc.contributor.author | 김기담 | - |
dc.contributor.author | 허재영 | - |
dc.contributor.author | 최유성 | - |
dc.contributor.author | 조문균 | - |
dc.contributor.author | 김수영 | - |
dc.date.accessioned | 2023-12-14T07:00:55Z | - |
dc.date.available | 2023-12-14T07:00:55Z | - |
dc.date.issued | 2023-06 | - |
dc.identifier.issn | 2384-1176 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/25715 | - |
dc.description.abstract | Secukinumab is a humanized monoclonal antibody against IL-17A approved for psoriasis and psoriatic arthritis. Recently, various eczematous reactions associated with IL- 17 inhibitor were reported as the most common paradoxical reaction. Although its mechanism is not well known, blocking the Th1/Th17 pathway could induce a paradoxical Th2 axis activation, which manifests as atopic eczema. A 57-year-old female patient presented with 30-year lasting chronic plaque psoriasis on her scalp, trunk, and both extremities. She had a history of asthma and denied any personal or familial history of atopic dermatitis. Initially, the patient was treated with cyclosporine for 1 year followed by 6 months of methotrexate, but only a partial response was achieved. She started receiving secukinumab and after 3rd injection, psoriasis improved while developing severe pruritic eczematous eruption. Secukinumab was discontinued after the 5th injection due to eczema aggravation and systemic therapy with cyclosporine was started to manage the paradoxical eczematous reaction. | - |
dc.format.extent | 4 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한건선학회 | - |
dc.title | Secukinumab으로 치료 중인 건선 환자에서 발생한 역설적 아토피 습 진양 반응 1예 | - |
dc.title.alternative | A case of Atopic Eczema-like Paradoxical Eruption in a patient with Psoriasis Receiving Secukinumab | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.bibliographicCitation | 대한건선학회지, v.20, no.1, pp 35 - 38 | - |
dc.citation.title | 대한건선학회지 | - |
dc.citation.volume | 20 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 35 | - |
dc.citation.endPage | 38 | - |
dc.identifier.kciid | ART002977525 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kciCandi | - |
dc.subject.keywordAuthor | Atopic eczema-like paradoxical eruption | - |
dc.subject.keywordAuthor | Psoriasis | - |
dc.subject.keywordAuthor | Secukinumab | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.